Showing results (111-120 of 2,345) with videos related to

Sort By:
Pageof 235
The AAPS Journal|November 23, 2019
Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-LifeYingting Cai, Shuo Zhou, Zhenyu Jin, et al.
The AAPS Journal|January 24, 2019
PBPK Absorption Modeling: Establishing the In Vitro-In Vivo Link-Industry PerspectiveCordula Stillhart, Xavier Pepin, Christophe Tistaert, et al.
The AAPS Journal|January 24, 2019
Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using HepatocytesHaruka Nishimuta, Takao Watanabe, Kiyoko Bando
The AAPS Journal|December 9, 2020
Correction to: Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung AbsorptionJohanna Eriksson, Erik Sjögren, Hans Lennernäs, et al.
The AAPS Journal|December 15, 2018
Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352AKun Peng, Yehong Wang, Ketevan Siradze, et al.
The AAPS Journal|December 29, 2017
Calibration Curves in Quantitative Ligand Binding Assays: Recommendations and Best Practices for Preparation, Design, and Editing of Calibration CurvesMitra Azadeh, Boris Gorovits, John Kamerud, et al.
The AAPS Journal|December 30, 2017
Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar AssessmentD Gouty, C C Cai, X Y Cai, et al.
The AAPS Journal|December 20, 2018
Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection ToolsSebastiaan C Goulooze, Elke H J Krekels, Thomas Hankemeier, et al.
The AAPS Journal|March 1, 2018
Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar AssessmentD Gouty, C C Cai, X Y Cai, et al.
The AAPS Journal|March 15, 2021
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)William P Bozza, Kazuyo Takeda, Wei-Lun Alterovitz, et al.
Pageof 235